JPMorgan Chase & Co’s Lunai Bioworks Inc. Common Stock RENB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.07K | Sell |
10,618
-118,364
| -92% | -$34.2K | ﹤0.01% | 5594 |
|
2025
Q1 | $70.1K | Sell |
128,982
-224,851
| -64% | -$122K | ﹤0.01% | 4908 |
|
2024
Q4 | $296K | Buy |
353,833
+260,823
| +280% | +$218K | ﹤0.01% | 4380 |
|
2024
Q3 | $45K | Buy |
93,010
+72,230
| +348% | +$34.9K | ﹤0.01% | 5018 |
|
2024
Q2 | $36.4K | Sell |
20,780
-99,568
| -83% | -$174K | ﹤0.01% | 5011 |
|
2024
Q1 | $319K | Buy |
120,348
+90,529
| +304% | +$240K | ﹤0.01% | 4211 |
|
2023
Q4 | $94.5K | Buy |
+29,819
| New | +$94.5K | ﹤0.01% | 4790 |
|
2023
Q3 | – | Sell |
-7,126
| Closed | -$4.04K | – | 6629 |
|
2023
Q2 | $4.04K | Sell |
7,126
-8,012
| -53% | -$4.54K | ﹤0.01% | 5312 |
|
2023
Q1 | $14K | Buy |
15,138
+3,952
| +35% | +$3.66K | ﹤0.01% | 5213 |
|
2022
Q4 | $12K | Buy |
11,186
+621
| +6% | +$666 | ﹤0.01% | 5075 |
|
2022
Q3 | $19K | Hold |
10,565
| – | – | ﹤0.01% | 4942 |
|
2022
Q2 | $20K | Buy |
+10,565
| New | +$20K | ﹤0.01% | 5060 |
|
2021
Q4 | – | Sell |
-10
| Closed | – | – | 5873 |
|
2021
Q3 | $0 | Sell |
10
-199
| -95% | – | ﹤0.01% | 5697 |
|
2021
Q2 | $1K | Sell |
209
-43,597
| -100% | -$209K | ﹤0.01% | 5427 |
|
2021
Q1 | $155K | Buy |
43,806
+3,176
| +8% | +$11.2K | ﹤0.01% | 4540 |
|
2020
Q4 | $120K | Buy |
40,630
+29,511
| +265% | +$87.2K | ﹤0.01% | 4270 |
|
2020
Q3 | $41K | Sell |
11,119
-1,488
| -12% | -$5.49K | ﹤0.01% | 4343 |
|
2020
Q2 | $54K | Sell |
12,607
-9,592
| -43% | -$41.1K | ﹤0.01% | 4195 |
|
2020
Q1 | $66K | Buy |
22,199
+3,002
| +16% | +$8.93K | ﹤0.01% | 4061 |
|
2019
Q4 | $97K | Buy |
19,197
+17,880
| +1,358% | +$90.3K | ﹤0.01% | 4038 |
|
2019
Q3 | $7K | Buy |
1,317
+214
| +19% | +$1.14K | ﹤0.01% | 4609 |
|
2019
Q2 | $5K | Sell |
1,103
-8,464
| -88% | -$38.4K | ﹤0.01% | 4705 |
|
2019
Q1 | $66K | Buy |
+9,567
| New | +$66K | ﹤0.01% | 4138 |
|